BDD Pharma Ltd

BDD Pharma Ltd is a specialized pharmaceutical services company that integrates early-phase formulation development, GMP manufacturing, and Phase I clinical research under a single service model known as Lean Clinical Development. By co-locating these capabilities, the company enables a modular, efficient pathway that removes traditional handovers and allows for rapid adjustments to formulations based on clinical data. Their technical infrastructure includes specialized expertise in oral drug delivery, particularly controlled-release platforms like their proprietary OralogiK technology, supported by in-house gamma scintigraphy and MHRA-licensed GMP facilities for small-batch clinical trial supply.

This integrated approach is designed to help pharmaceutical and biotech partners accelerate early-stage development, optimize drug product performance, and minimize waste in the transition from First-in-Human trials to Phase II. BDD serves a broad range of therapeutic areas, including neurology, gastroenterology, and respiratory health, providing clients with comprehensive CRO services, regulatory support, and expert project management. The company, which evolved from the 2017 merger of Bio-Images Research Ltd and Drug Delivery International, leverages over 25 years of experience to provide data-driven, agile clinical development services that prioritize speed and scientific rigor for their global partners.